News

AddToAny

Google+ Facebook Twitter Twitter

Novel Covid test

A new rapid test has been developed that is 98.3% accurate for positive COVID-19 tests and 96% for negative tests.

The novel COVID-19 test uses a mass spectrometer, which is paired with a powerful machine-learning platform to detect SARS-CoV-2 in nasal swabs.

The mass spectrometer can analyse samples in minutes, with the entire process taking a total of about 20 minutes.

The accuracy matches or outperforms many of the current COVID-19 screening tests, it is claimed.

The new testing method may allow for the rapid screening of large numbers of individuals for businesses, schools, venues and other large facilities.

This is the first test for COVID-19 that pairs mass spectrometry with robotics and a robust automated machine-learning platform to rapidly deliver test results.

The coupling of these unique elements not only allows testing for COVID-19, but may be able to quickly adapt to detect other diseases and perhaps future pandemic organisms.

go.nature.com/3e8pGb9

Image credit | iStock

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top